In the affidavit, the Uttarakhand government submitted that its state licensing authority has issued a public notice stating that publishing advertisements contrary to law will attract strict disciplinary and legal action, including fine, imprisonment or both.
The affidavit filed by the State Licensing Authority, Ayurvedic and Unani Services, said it sought permission on April 12 from the Drug Inspector, Haridwar, to lodge a complaint against Divya Pharmacy and Patanjal Ayurveda Ltd for repeated violations of the Drugs and Magic Remedy Act. Has given. (Objectionable Advertisements) Act, 1954.
"The SLA issued an order dated April 15, 2024, to Divya Pharmacy and Responden No. 5-Patanjali Ayurved Limited, stating that the manufacturing license for their 14 products, namely 'Swasari Gold', 'Swasari Vati, Bronkom' 'Swasari Pravahi', 'Swasari Avaleh', 'Muktavati Extra Power', 'Lipidome', 'B Grit', 'Madhugrit', 'Madhunashinivati Extra Power', 'Livamrit Advance' 'Livogrit', 'iGrit Gold' and 'Patanjali Drishti' 'Eye Drop' has been suspended with immediate effect under Rule 159(1) of the Drugs and Cosmetics Rules, 1945," I said.
"District Ayurvedic and Unani Officer, Haridwar filed a criminal complaint under Sections 3, 4 and 7 of the Drugs and Magic Remedies (Objectionable Advertisements) Act against Swami Ramdev, Acharya Balkrishna, Divya Pharmacy and Patanjali Ayurveda Limited before the Chief Judicial Magistrate, Haridwar. “Registered under the Act, 1954,” added the affidavit.The SLA said it will continue to take all appropriate and further steps against Divya Pharmacy and Patanjali Ayurved Limited as per the procedure laid down in law and the directions issued by the Supreme Court.
In an order passed on April 10, the top court directed the then Joint Director of the State Licensing Authority and all the officers holding the post of District Ayurvedic and Unani Officer, Haridwar from 2018 till date to file their respective affidavits explaining the inaction. Had ordered. Their share.
The Indian Medical Association has sought action against Patanjali for violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, which prohibits advertising of certain products to treat specific diseases and disorders, including diabetes, heart disease, high or low blood pressure. Imposes restrictions. And obesity.
The Ayurvedic company had earlier given an undertaking before the Supreme Court that it would not make any incidental statement claiming medicinal efficacy of its products or advertise or brand them in violation of law and would not make any complaint against any system of medicine. Will not issue statement.In any form of media.
The affidavit filed by the State Licensing Authority, Ayurvedic and Unani Services, said it sought permission on April 12 from the Drug Inspector, Haridwar, to lodge a complaint against Divya Pharmacy and Patanjal Ayurveda Ltd for repeated violations of the Drugs and Magic Remedy Act. Has given. (Objectionable Advertisements) Act, 1954.
"The SLA issued an order dated April 15, 2024, to Divya Pharmacy and Responden No. 5-Patanjali Ayurved Limited, stating that the manufacturing license for their 14 products, namely 'Swasari Gold', 'Swasari Vati, Bronkom' 'Swasari Pravahi', 'Swasari Avaleh', 'Muktavati Extra Power', 'Lipidome', 'B Grit', 'Madhugrit', 'Madhunashinivati Extra Power', 'Livamrit Advance' 'Livogrit', 'iGrit Gold' and 'Patanjali Drishti' 'Eye Drop' has been suspended with immediate effect under Rule 159(1) of the Drugs and Cosmetics Rules, 1945," I said.
"District Ayurvedic and Unani Officer, Haridwar filed a criminal complaint under Sections 3, 4 and 7 of the Drugs and Magic Remedies (Objectionable Advertisements) Act against Swami Ramdev, Acharya Balkrishna, Divya Pharmacy and Patanjali Ayurveda Limited before the Chief Judicial Magistrate, Haridwar. “Registered under the Act, 1954,” added the affidavit.The SLA said it will continue to take all appropriate and further steps against Divya Pharmacy and Patanjali Ayurved Limited as per the procedure laid down in law and the directions issued by the Supreme Court.
In an order passed on April 10, the top court directed the then Joint Director of the State Licensing Authority and all the officers holding the post of District Ayurvedic and Unani Officer, Haridwar from 2018 till date to file their respective affidavits explaining the inaction. Had ordered. Their share.
The Indian Medical Association has sought action against Patanjali for violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, which prohibits advertising of certain products to treat specific diseases and disorders, including diabetes, heart disease, high or low blood pressure. Imposes restrictions. And obesity.
The Ayurvedic company had earlier given an undertaking before the Supreme Court that it would not make any incidental statement claiming medicinal efficacy of its products or advertise or brand them in violation of law and would not make any complaint against any system of medicine. Will not issue statement.In any form of media.
